Mannich Ketones as Possible Antimycobacterial Agents

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• Tuberculosis remains a significant global health challenge, necessitating the development of novel therapeutic agents.
• Existing treatments like isoniazid (INH) face challenges such as drug resistance and limited spectrum of activity.
• Mannich ketones and their derivatives represent a class of compounds with potential antimicrobial properties.

Purpose of the Study:

• To evaluate the antitubercular efficacy of known unsaturated and fused Mannich ketones and their reduced derivatives (amino alcohols).
• To compare the antimycobacterial activity and spectrum of these compounds against standard drugs like isoniazid.
• To elucidate the mechanism of action of the most promising compounds.

Main Methods:

• Screening of 23 Mannich ketones and amino alcohols against Mycobacterium tuberculosis, M. xenopi, and M. gordonae.
• Determination of minimum inhibitory concentrations (MICs) and comparison with isoniazid.
• Investigation of the mode of action using transmission electron microscopy (TEM), high-performance liquid chromatography (HPLC), and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS).
• Structure-activity relationship (SAR) analysis.

Main Results:

• Several Mannich ketone derivatives demonstrated potent antimycobacterial activity, comparable to isoniazid.
• The tested compounds exhibited a broader spectrum of activity against mycobacterial strains than isoniazid.
• Mechanism of action studies suggested inhibition of mycobacterial cell wall biosynthesis as a likely pathway.

Conclusions:

• Mannich ketones and their amino alcohol derivatives are promising candidates for novel antitubercular drug development.
• These compounds offer potential advantages over isoniazid due to their broader antimycobacterial spectrum.
• Further research into the inhibition of cell wall biosynthesis could lead to targeted therapeutic strategies.